Abstract
We isolated new gyrA and gyrB mutations in Escherichia coli which have a graded effect on DNA supercoiling. The mutants, selected respectively for resistance to nalidixic acid and coumermycin, were sorted by means of a rapid in vivo assay of DNA gyrase activity (Aleixandre and Blanco 1987). Cells carrying a gyrB (Cour) mutation usually showed a decrease in DNA supercoiling, which would indicate a reduction in gyrase activity. In contrast, most of the gyrA (Nalr) mutations had no significant effect on DNA supercoiling. Moreover, they conferred a high level of resistance to nalidixic acid and other quinolones, thus being similar to the gyrA (Nalr) mutants currently used. We also detected rare gyrA mutants showing a reduction in DNA gyrase activity. These mutants were, in addition, resistant to only low concentrations of quinolones, which allowed us to use the phenotype of partial quinolone resistance as an indicator to score gyrA mutations affecting DNA supercoiling. When gyrB mutations were introduced into the gyrA mutants, these became more sensitive to quinolones and a decrease in supercoiling was observed. Moreover, the topA10 mutation sensitized gyrA (Nalr) cells to quinolones. We conclude therefore that the GyrA-dependent quinolone resistance is diminished as a consequence of the reduction either in topoisomerase I or gyrase activities.
MeSH Terms
Aminocoumarins
Ampicillin/pharmacology
Anti-Infective Agents/pharmacology
Coumarins/pharmacology
DNA Topoisomerases, Type I/metabolism
DNA Topoisomerases, Type II/genetics,metabolism
DNA, Bacterial/metabolism
DNA, Superhelical/metabolism
Drug Resistance, Microbial/genetics
Escherichia coli/genetics
Mutation
Nalidixic Acid/pharmacology
Plasmids
Chemicals
Aminocoumarins
Anti-Infective Agents
Coumarins
DNA, Bacterial
DNA, Superhelical
Nalidixic Acid
Ampicillin
DNA Topoisomerases, Type I
DNA Topoisomerases, Type II
coumermycin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Aleixandre V
Instituto de Investigaciones Citológicas, Centro asociado del CSIC, Valencia, Spain.
Urios A
Herrera G
Blanco M
References (22)
22 references, click to expand
-
Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
J Bacteriol. 1986 Oct;168(1):276-82
PMID: 3019999
-
Mutations in the gene coding for Escherichia coli DNA topoisomerase I affect transcription and transposition.
Proc Natl Acad Sci U S A. 1981 May;78(5):2747-51
PMID: 6265907
-
Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.
Proc Natl Acad Sci U S A. 1977 Nov;74(11):4772-6
PMID: 337300
-
Biology of bacterial deoxyribonucleic acid topoisomerases.
Microbiol Rev. 1984 Dec;48(4):273-89
PMID: 6097803
-
Quinolone-resistant mutations of the gyrA gene of Escherichia coli.
Mol Gen Genet. 1988 Jan;211(1):1-7
PMID: 2830458
-
Lambda transducing phages for the nalA gene of Escherichia coli and conditional lethal nalA mutations.
Mol Gen Genet. 1978 Nov 29;167(2):129-37
PMID: 366382
-
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.
Biochemistry. 1989 May 2;28(9):3886-94
PMID: 2546585
-
DNA supercoiling in gyrase mutants.
J Bacteriol. 1984 May;158(2):397-403
PMID: 6327603
-
Inhibitors of DNA topoisomerases.
Biochemistry. 1988 Apr 5;27(7):2253-9
PMID: 2838070
-
Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.
Proc Natl Acad Sci U S A. 1985 Jan;82(2):307-11
PMID: 2982149
-
Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.
Proc Natl Acad Sci U S A. 1977 Nov;74(11):4767-71
PMID: 200930
-
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Proc Natl Acad Sci U S A. 1976 Dec;73(12):4474-8
PMID: 794878
-
DNA topoisomerases.
Annu Rev Biochem. 1985;54:665-97
PMID: 2992360
-
Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes.
Cell. 1982 Nov;31(1):35-42
PMID: 6297751
-
Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes.
Cell. 1982 Nov;31(1):43-51
PMID: 6297752
-
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA.
Biochemistry. 1989 May 2;28(9):3879-85
PMID: 2546584
-
Pedigrees of some mutant strains of Escherichia coli K-12.
Bacteriol Rev. 1972 Dec;36(4):525-57
PMID: 4568763
-
Heterogeneity in the level of ampicillin resistance conferred by pBR322 derivatives with different DNA supercoiling.
Mol Gen Genet. 1987 Aug;209(1):56-60
PMID: 3312957
-
Genetic analysis of mutations that compensate for loss of Escherichia coli DNA topoisomerase I.
J Bacteriol. 1985 Jun;162(3):1173-9
PMID: 2987184
-
DNA topoisomerases.
Annu Rev Biochem. 1981;50:879-910
PMID: 6267993
-
Regulation of DNA supercoiling in Escherichia coli.
Cold Spring Harb Symp Quant Biol. 1983;47 Pt 2:763-7
PMID: 6305584
-
The genetic control of DNA supercoiling in Salmonella typhimurium.
EMBO J. 1984 Aug;3(8):1745-52
PMID: 6090123